Fig. 5From: Cardioprotective function of sclerostin by reducing calcium deposition, proliferation, and apoptosis in human vascular smooth muscle cellsCalcium and phosphate determinations under different calcifying conditions in HAoSMCs. (A) (B) Extracellular and intracellular calcium concentrations (µg calcium/µg protein), (C) (D) extracellular and intracellular phosphate (nmol phosphate/µg protein). All determinations were measured in mock and HAoSMCs overexpressing sclerostin, under non-calcifying and calcifying conditions. (E) Representative microphotographs obtained at 5X magnification of Alizarin Red staining of mock and HAoSMCs overexpressing sclerostin, under both non-calcifying (top) and calcifying (bottom) conditions and normalized by total protein content. Scalebars: 200 μm. Calcium mineral depositions were analyzed in the different conditions and results were expressed as the OD 405 nm/µg protein; n = 3 biological replicates/group and n = 3 technical replicates/ biological replicates were performed. Data are represented as the mean ± standard deviation. The p-values between groups were determined by the unpaired Student´s t-test. In the figure A and C * = p < 0.05 vs. non-calcifying conditions. In figure B, * = p < 0.05 vs. calcified mock. HAoSMCs, Primary Human Aortic Smooth Muscle Cells; OD, optical density.Back to article page